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ABSTRACT 
Menstrual abnormalities are common in women nowadays due to lifestyle modifications, changes in 
dietary habits and lack of excercise. Of these menstrual disorders, amenorrhoea or absence of 
menstruation is a common clinical presentation for abnormalities of hypothalamo pituitory ovarian axis. 
Ayurvedic treatise, Vaidya Manorama and Chikitsamanjary mentions the use of root of Amleeka in 
treating Nastarthava (Amenorrhoea) – which is absence or abnormal cessation of menstruation. 
Amenorrhoea causes much physical and psychological problems to affected women. Considering the 
disease scenario, drawbacks of existing treatment modalities in modern medicine (which advocates 
greater use of steroids, hormones or surgery), effectiveness of the drug used by traditional practitioners 
and its easy availability, it seems ideal to investigate the effect of root of Amleeka in Nashtartava so as to 
provide a safe and affordable treatment. The clinical trial was undertaken as a before and after trial with 
30 patients for a period of 3 months with the test drug and three months follow up. The assessment 
criteria were the amount and duration of menstrual bleeding, interval of menstrual cycle and associated 
symptoms before trial, after trial and after follow up. The trial drug was found to be effective in 
improving amount of menstrual bleeding from scanty to moderate and duration of bleeding from short 
to moderate level (P<0.001***). Thus it can be concluded that study drug is effective in inducing 
menstruation. 
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INTRODUCTION
 Ayurveda – the life science, a traditional 
documented system of health care, provides a number of 
useful and harmless medicaments including single drug 
therapies which were shown effective through prior 
experiences. Amleeka (Tamarindus indica Linn.) is one 
such a common and useful drug described under Amla 
varga (group of sour drugs) belonging to family – 
Caesalpiniaceae. Ayurvedic treatise like Chikitsa manjary 
and Vaidya Manorama prescribes the use of root of 
Amleeka in treating Nastarthava (Amenorrhoea)[1,2].  
 Nastarthava (amenorrhoea) can be defined as 
absence or abnormal cessation of menstruation, which is 
a common clinical presentation for abnormalities of 
hypothalamo pituitary ovarian axis. Amenorrhoea causes 
much physical and psyschological problems to affected 
women. It has become a leading cause of infertility today 
which lead to an unhealthy family life. Due to changes in 
lifestyle, dietary habits, lack of exercise and various 
environmental factors the prevalence of amenorrhoea is 
higher now a days[3,4]. Ethno botanical surveys revealed 
that Amleeka is being used by many rural traditional 
practitioners to induce menstruation in amenorrhoea as 
being a common and easily available drug and so far no 
toxicity reported[ 5]. As evidence based medicine is the 
need of the hour, this study was an attempt to develop a 
scientific rationale regarding the use of root of Amleeka in 
Nashtartava. 
Objective of the study 
To clinically evaluate the effect of root of Amleeka 
(Tamarindus indica Linn.) in Nastarthava (amenorrhoea) 
by orally administering drug for three consecutive 
months and clinically assessing signs and symptoms 
before treatment, after treatment and after follow up. 
MATERIALS AND METHODS  
Study design - interventional study. 
Selection of patients – Women of age group 18-45 years 
complaining of absence of menstruation for last 3 or more 
months consecutively were selected from OPD of 
Department of Dravyagunavijnan, Govt.Ayurveda College 
Trivandrum. 
Exclusion criteria  
 Patients with primary amenorrhoea. 
 Patients with gross structural abnormalities of uterus, 
thyroid disease 
 Patients taking steroid medications or under long term 
medication for chronic illness. 
 Subjects who are not co-operative. 
 Collection of data 
 The data was collected as per a case proforma. 
History of all cases including their age, occupation, socio 
economic status, educational status, personal history, 
history of present and past illness, menstrual history, 
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obstetric and treatment history were collected. General 
and systemic examination were done to find and rule out 
other systemic or structural abnormalities. 
Investigations  
 Haematological examination, Abdominal 
ultrasonography done before study to find out any 
ovarian or uterine pathology for amenorrhoea, 
Hormonal assay (FSH, LH and Prolactin) done before 
study to find out hormonal imbalance. 
Assessment criteria  
a) Amount of blood loss : 
 Since the exact amount of blood loss was very 
difficult to measure, the number of pads used by the 
patient with the area of soaking was considered to assess 
the amount of bleeding and were graded as  
Scanty (0) -  1- 2 pads per day with minimum soaking.  
Moderate (1)- 2 - 4 pads per day with complete soaking. 
Excessive (2)- More than 4 pads per day with complete 
soaking 
b) Duration of graded as 
 Short (0) - 1-2 days. 
 Moderate (1)- 3-7 days. 
 Excess (2) - greater than 7 days. 
c) Interval of menstruation d) Clots – Present or absent. 
 Frequent (0) - less than 21 days. 
 Normal (1) - 21-35 days.  
 Delayed (2) - more than 35 days. 
Associated symptoms like Anaemia, Body weight, 
General body weakness, Pain during menstruation, 
Abdominal distension, Appetite, Hyper pigmentation of 
skin were also assessed  
Treatment procedure 
 Selected 30 patients were given 6g of powdered 
drug mixed with 48 ml of milk morning and evening before 
food twice daily. Drug was administered consecutively for 
three months, stopped during menstruation, then again 
continued with strict diet control and exercise. Amount 
and duration of menstrual bleeding, interval of menstrual 
cycle, and associated symptoms was assessed before 
treatment, after treatment and after follow up. During the 
follow up period no drug was administrated.  
Statistical analysis - Values obtained were statistically 
evaluated using paired t test, Friedman’s test and 
Wilcoxon’s signed rank test. In datas related to clinical 
picture, anova test is not used. As non- parametric 
methods are used for analysing the data, normality 
assumption has been violated in the case of all parameters 
(by Colmogorov-Smirnov test, P <0.001 ⃰ ⃰ ⃰ ). 
Ethical consideration - Every patient was selected after 
getting an informed consent from them. Before starting 
study consent from the authorities was also obtained. 
OBSERVATION AND RESULTS  
Out of 30 patients majority belongs to age group 
20-39 having a medium body built taking mixed diet 
mainly nonvegetarian. The complaints of menstrual 
irregularity is more with people taking non vegetarian diet 
consisting mostly poultry items which were grown using 
hormones. About 57% of the patients had moderate nature 
of work, but the duration of amenorrhoea was seen 
increased in patients who followed a sedentary mode of 
life. Lack of exercise and sedentary mode of life may cause 
obesity, insulin resistance and anovulation which may lead 
to amenorrhoea. Most of the patients had their body mass 
index (BMI) around 25 and beyond 25, indicating a 
relationship between amenorrhoea and BMI. Also patients 
with high BMI had increased body weight. 
 Majority of the patients had the duration of illness 
above 2 years. About 43.3% of the patients required less 
than 20 days for induction of menstruation with treatment 
and 23.3% required greater than 40 days. Analyzing the 
character of menstruation it was observed that, 80 % of 
the patients had scanty bleeding requiring only one or two 
pads, 67% of the patients were having short duration of 
bleeding lasting for about 1 or 2 days. All patients had 
delayed intervals of menstruation. About 67% of patients 
had clots along with menstrual bleeding and 10% had 
severe pain. Among the associated symptoms, the most 
prominent one was abdominal distension (63.3%), then 
decrease in appetite (37%), general body weakness (40%), 
hyper pigmentation of skin (37%), increased body weight 
(13.3%) etc.  
 Table and graph no.1 showing no: of days required for 
induction of menstruation 
No of days Count percentage 
< 20 days 13 43.3 
20–40 days 10 33.3 
>40 days 7 23.3 
Total 30 100 
 
About 43.3% of the patients required only less than 20 
days for induction of menstruation with the medicine, 
33.3% required 20 -40 days and 23.3% required greater 
than 40 days. 
Table and graph no.2 showing data of effectiveness of 
treatment on amount of bleeding 
 BT AT AF 
Bleeding F % F % F % 
0 24 80 8 26.7 9 30 
1 1 3.3 18 60 19 63.3 
2 5 16.7 4 13.3 2 6.7 
  
< 20 days
20 - 40 days
> 40 days
33.3 
%
43.3 %
23.3 
%
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 From the table, it is seen that before the treatment 
majority (80%) of the patients were in scanty bleeding 
category. After treatment the percentage improved to 
60%. But with the withdrawal of medicine, i.e., during 
follow up – 30% patients retrieved to scanty bleeding 
pattern. Wilcoxon’s Signed Rank test showed that the 
treatment had significant effect before treatment and after 
treatment, (P< 0.001), before treatment and after follow 
up (P< 0.01), but after treatment and after follow up it is 
not significant (P>0.05). 
Table and graph no.3 showing data of effectiveness of 
treatment on duration of bleeding 
 
 
 
 
 
 
 
 From table, it is seen that before the treatment 
majority (66.7%) of the patients had less duration of 
bleeding, after treatment it reduced to 3.3% and 90% of 
patients came to moderate or normal bleeding category 
but after follow up 13.3% of patients retrieved to less 
bleeding category. Wilcoxon’s Signed Rank test showed 
that the treatment has significant effect before treatment 
and after treatment (P< 0.001), before treatment and after 
follow up (P<0.001) and after treatment and after follow 
up it is not significant (P>0.05).  
 
Table showing data of effectiveness of treatment on 
interval of bleeding 
 
 
 From table it is seen that, all patients had delayed 
menstrual interval before treatment. After treatment 
36.7% came to normal interval and after follow up it 
became 16.7% Wilcoxon’s Signed Rank test showed that 
the treatment has significant effect before treatment and 
after treatment (P<0.001), before treatment and after 
follow up (P<0.05), and after treatment - after follow up 
(P>0.05) it is not significant.  
 On analysis of clot during menstruation, majority 
(66.7%) of the patients had clots, but after treatment it 
reduced to 26.7% and after follow up it retrieved to 33.3%. 
Wilcoxon’s Signed Rank test showed that the treatment 
has significant effect before treatment and after treatment 
(P<0.001). On analysis of pain during menstruation, before 
treatment 10% of the patients had severe pain. But after 
treatment none of the patients had severe pain. Wilcoxon’s 
Signed Rank test showed that the treatment has significant 
effect before treatment and after treatment (P<0.001). 
DISCUSSION  
Most of the patients with hirsuitism and hyper 
pigmentation of skin has polycystic ovarian disease. 
Considering Dosha predominance in patients, most of them 
(70%) were of Vata kapha prakriti. In addition to Prakriti, 
mode of life including food - junk foods, bakery items, 
sedentary nature of work etc may lead to vitiation of 
Kapha, psychological stress and anxiety may causes a Vata 
vitiation. All these may leads to Srothorodha and 
Amavastha which inturn added to the pathogenesis of 
disease. In hormonal assay done before study, no 
significant hormonal imbalance was seen. However serum 
prolactin of some patients seems to be raised. In 
abdominal ultrasound done to find out ovarian or uterine 
pathology for amenorrhoea, 66% of the patients had 
polycystic appearance of ovaries. While analysing the 
blood investigation, about 50% of patients had Hb% less 
than 12 gms% before treatment and after treatment there 
was only slight improvement observed. It was also 
BT AT AF
80
26.7 30
3.3
60 63.3
16.7 13.3 6.7
Scanty Moderate Excessive
BT AT AF
66.7
3.3
13.3
13.3
90 63.3
20
6.7
23.3
Short Moderate Excessive
BT AT AF
0 0 00
36.7
16.7
100
63.3
83.3
Frequent Normal Delayed
 BT AT AF 
Duration F % F % F % 
0 20 66.7 1 3.3 4 13.3 
1 4 13.3 27 90 19 63.3 
2 6 20 2 6.7 7 23.3 
 BT AT AF 
Interval  F % F % F % 
0 0 66.7 1 3.3 4 13.3 
1 0 13.3 27 90 19 63.3 
2 30 20 2 6.7 7 23.3 
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observed that many patients with general body weakness 
has less haemoglobin percentage. 
After treatment, the duration and amount of 
menstrual bleeding of most patients showed significant 
improvement from the short and scanty grade to 
moderate(P<0.001***).Clots reduced from 66.7% before 
treatment to 33.3% after follow up (P< 0.001***). Pain also 
reduced from severe grade to moderate or mild. 
 In case of interval between menstrual cycle, only 
36.7% came to normal interval after treatment(P<0. 05). 
The effect of drug was found to be more just after 
treatment than after follow up showing drug has action 
mainly during the time of medicine intake. Considering the 
associated symptoms, it was observed that they generally 
decreased with resolving of chief complaints. Most 
remarkable changes were noticed in case of abdominal 
distension (P< 0.001***) and body weight which decreased 
from increasing nature (P< 0.001***). In the follow up, it 
was noticed that most of the symptoms reappeared, but 
was not as severe as before.  
From the study it was observed that, effect of the drug was 
more in patients having amenorrhoea for short duration. 
The amount and duration bleeding improved from scanty 
and short grade to moderate level in most patients. But the 
interval of menstrual cycle seems to be extended in almost 
all cases. Thus it can be concluded that the drug is effective 
in inducing menstruation but is not able to regularize it. 
The drug was found to be more effective with strict diet 
control and exercise. 
CONCLUSION  
 The root bark of Amleeka (Tamarindus indica Linn.) 
has significant effect in improving the amount of 
menstrual bleeding from scanty to moderate and 
duration from short to moderate.  
 The study drug is effective in reducing clots, 
menstrual pain and abdominal distention. General 
body weakness and appetite showed slight 
improvement. 
 The study drug was found to be effective in inducing 
menstruation but not able to regularize menstrual 
cycle. 
 The medicine was found to be more effective in 
amenorrhoea of recent onset. 
  The study drug appears to be a safe combination in 
the management of Nastarthava as no adverse effects 
were observed during the study. 
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